| Anidulafungin | Micafungin | P |
---|---|---|---|
(n = 30) | (n = 33) | ||
Candida score at start | 3 (2) | 3 (3) | 0.71 |
Source of isolatesa | Â | Â | 0.25 |
 Blood | 10 (33) | 12 (36) |  |
 Intra-abdominal fluid | 17 (57) | 20 (63) |  |
 Pleural fluid | 3 (10) | 1 (3) |  |
Candida spp. a | Â | Â | 0.46 |
 Candida albicans | 8 (27) | 3 (9) |  |
 Candida dublienis | 0 (0) | 2 (6) |  |
 Candida glabrata | 17 (57) | 21 (66) |  |
 Candida krusei | 3 (10) | 3 (10) |  |
 Candida parapsilosis | 1 (3) | 2 (6) |  |
 Candida tropicalis | 1 (3) | 2 (6) |  |
Global responsea | 21 (67) | 23 (70) | 0.80 |
Clinical responsea | 24 (80) | 28 (85) | 0.62 |
Microbial responsea | 21 (70) | 24 (73) | 0.81 |
 Gaining negative culturesa | 18 (60) | 20 (60) | 0.96 |
Duration of infection (days) | 3 (5) | 3 (5) | 0.80 |
Duration of treatment (days) | 12 (8) | 14 (9) | 0.40 |
Length of ICU stay (days) | 13 (15) | 14 (21) | 0.64 |
Mortality day 28 after starta | 20 (67) | 18 (55) | 0.33 |
Mortality day 90 after starta | 26 (87) | 21 (64) | 0.04 |